OESTROGEN RECEPTOR POSITIVE BREAST CANCER

This adverse event was reported 125 times

These drugs are most commonly taken by patients reporting OESTROGEN RECEPTOR POSITIVE BREAST CANCER:

# Drug Count
0 EXEMESTANE 14
1 LETROZOLE 13
2 LETROZOLE TABLETS 13
3 LEVONORGESTREL 13
4 FINASTERIDE 12
5 ANASTROZOLE 9
6 FULVESTRANT 9
7 LEVOTHYROXINE SODIUM 9
8 ESTROGENS, CONJUGATED 8
9 METHOTREXATE SODIUM 8
See all common drugs associated with OESTROGEN RECEPTOR POSITIVE BREAST CANCER

OESTROGEN RECEPTOR POSITIVE BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 9 0.0002
1 Aromatase Inhibitor [EPC] 24 0.0002
2 Provitamin D2 Compound [EPC] 4 0.0001
3 5-alpha Reductase Inhibitor [EPC] 12 0.0001
4 Estrogen [EPC] 15 0.0001
5 Ester Local Anesthetic [EPC] 3 0.0001
6 Nitrofuran Antibacterial [EPC] 1 0.0001
7 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
8 Potassium Channel Blocker [EPC] 4 0.0001
9 Progestin [EPC] 14 0.0000
See all drug classes enriched for association with OESTROGEN RECEPTOR POSITIVE BREAST CANCER